{"product_id":"straumann-business-model-canvas","title":"Straumann Holding Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStraumann Business Model Canvas: Clear Strategy Snapshot for Investors \u0026amp; Founders\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore Straumann Holding's business model through a focused Business Model Canvas that shows how the company serves dental professionals, builds strategic partnerships, and monetizes a broad portfolio of implants, digital tools, aligners, and biomaterials; download the full Word\/Excel canvas for a practical, detailed view designed for investors, consultants, and founders.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStraumann partners with over 60 universities and dental schools worldwide, funding clinical trials that contributed to a 12% rise in implant-related peer-reviewed publications from 2020-2024; these studies validate products and support regulatory filings across 50+ countries. By tying R\u0026amp;D spend-CHF 239 million in 2024-to academic collaborations, Straumann keeps implants and biomaterials aligned with top scientific evidence and biotech advances.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Team for Implantology\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe International Team for Implantology (ITI) is Straumann's primary strategic partner, giving access to 17,000+ clinicians across 70+ chapters and independent scientific expertise that underpins training and guidelines; ITI-linked education contributed to a 2024 Straumann training reach of ~45,000 clinicians and supported product adoption driving ~€1.8bn implant-related revenue in 2024. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Technology and Software Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpcollaborations with digital-technology firms let straumann integrate intraoral scanners and cad software into its ecosystem supporting digital revenue of group sales these partnerships keep a seamless workflow from diagnosis to final prosthetic placement ensure compatibility evolving standards like dentalx stl open formats.\u003e\n\u003c\/pcollaborations\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLarge Dental Service Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStraumann forms alliances with global Dental Service Organizations (DSOs) to lock multi-year supply deals and standardized protocols, driving corporate-channel penetration and supporting ~CHF 1.9bn in implant-related revenue in 2024.\u003c\/p\u003e\n\u003cp\u003eDSOs receive tailored training, integrated logistics, and volume pricing, enabling high-volume sales and faster clinic rollouts.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMulti-year supply contracts\u003c\/li\u003e\n\u003cli\u003eStandardized treatment protocols\u003c\/li\u003e\n\u003cli\u003eSupports CHF 1.9bn implant revenue (2024)\u003c\/li\u003e\n\u003cli\u003eCustomized training \u0026amp; logistics\u003c\/li\u003e\n\u003cli\u003eScales corporate dentistry channels\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAuthorized Distribution and Logistics Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIn territories without direct sales, Straumann uses vetted distributors to reach clinicians, ensuring service and technical support parity with the parent company; in 2024 distributors covered roughly 35% of Straumann Group revenues (~CHF 700m of CHF 2.0bn implant-related sales).\u003c\/p\u003e\n\u003cp\u003eThis authorized-distributor network secures product availability in emerging markets, supporting 50+ markets where local regulatory or cost structures limit direct presence.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e35% revenue via distributors in 2024 (~CHF 700m)\u003c\/li\u003e\n\u003cli\u003eCoverage: 50+ markets\u003c\/li\u003e\n\u003cli\u003eSelection: training, service-level parity, regulatory compliance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStraumann's 60+ partnerships fuel CHF2.0bn implants, CHF530m digital \u0026amp; CHF239m R\u0026amp;D\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStraumann's key partnerships-60+ universities, ITI (17,000+ clinicians), digital partners, DSOs, and 35% distributor-covered markets-supported CHF 2.0bn implant revenue (2024), CHF 239m R\u0026amp;D (2024), ~45,000 clinician trainings (2024), and CHF 530m digital revenue (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUniversities\u003c\/td\u003e\n\u003ctd\u003eR\u0026amp;D \u0026amp; publications\u003c\/td\u003e\n\u003ctd\u003e60+ partners; CHF 239m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eITI\u003c\/td\u003e\n\u003ctd\u003eClinician network\u003c\/td\u003e\n\u003ctd\u003e17,000+; ~45,000 trained\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital partners\u003c\/td\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eCHF 530m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDSOs\u003c\/td\u003e\n\u003ctd\u003eImplant revenue support\u003c\/td\u003e\n\u003ctd\u003e~CHF 1.9bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003eRevenue share; markets\u003c\/td\u003e\n\u003ctd\u003e35%; 50+ markets\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas for Straumann Group covering customer segments, channels, value propositions, key activities, resources, partners, cost structure, and revenue streams, reflecting real-world dental implant and restorative solutions operations and strategic plans.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of Straumann Holding's business model with editable cells to quickly map its implant, orthodontics, and biomaterials value chains and relieve pain from scattered strategic insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Research and Product Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStraumann's R\u0026amp;D drives continuous innovation in surface tech and materials-programs in 2024 invested ~CHF 229m (R\u0026amp;D + product dev), targeting faster osseointegration to cut healing times and raise implant success in compromised sites by ~5-8% in published trials; teams also develop new clear-aligner polymers and digital diagnostics, supporting the company's 2024 implant \u0026amp; prosthetics revenue growth of ~12% YoY.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Precision Manufacturing and Quality Control\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStraumann operates high-tech plants in Switzerland and the US that machine dental implants to tolerances under 10 microns and produced ~1.2m implant components in 2024; inline metrology and 100% batch traceability back every device, with QA yields \u0026gt;99.5% and CAPA cycles averaging 14 days-standards that sustain CE\/FDA compliance and trust among 40,000+ clinician partners globally.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProfessional Education and Clinical Training\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStraumann invests ~CHF 120m yearly in professional education and clinical training (2024 report), running 1,200+ workshops, 800+ webinars and 350 hands-on courses that train dentists on implants and orthodontic systems to boost correct use and outcomes.\u003c\/p\u003e\n\u003cp\u003eEducation drives adoption: trained clinicians account for ~45% higher product uptake and support recurring revenues from consumables and service contracts, reinforcing brand loyalty and long-term market share gains.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Ecosystem and Software Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eStraumann develops proprietary software for treatment planning and practice management that links scans, CAD\/CAM, and patient records; in 2024 Straumann's digital segment grew ~18% and accounted for roughly 12% of group sales (~CHF 330m), highlighting platform importance.\u003c\/p\u003e\n\u003cp\u003eContinuous updates, cloud maintenance, and security patches keep workflows predictable and reduce chair time variability; in trials digital planning cut surgical time by ~20% and improved case acceptance rates ~15%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eProprietary platforms integrate imaging, CAD\/CAM, records\u003c\/li\u003e\n\u003cli\u003eDigital segment ≈CHF 330m in 2024 (12% sales)\u003c\/li\u003e\n\u003cli\u003eUpdates\/cloud support ensure security and uptime\u003c\/li\u003e\n\u003cli\u003eDigital planning: -20% surgical time, +15% case acceptance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Marketing and Sales Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGlobal marketing at Straumann Group (Straumann Holding AG) positions premium and value brands across 70+ markets, driving patient-facing campaigns and product launches that supported 2024 revenue of CHF 1.6bn in Dental Implants and Restorative segments; messaging is localized but brand guidelines ensure cohesion.\u003c\/p\u003e\n\u003cp\u003eSales teams use consultative selling-technical reps and lab specialists-to train clinicians, contributing to a \u0026gt;30% attach rate for prosthetics and boosting recurring revenue; regional ops adapt pricing, CRO and service models to local reimbursement and clinic size.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePresent in 70+ markets, CHF 1.6bn revenue (2024) in key segments\u003c\/li\u003e\n\u003cli\u003eConsultative reps + lab techs drive \u0026gt;30% prosthetics attach rate\u003c\/li\u003e\n\u003cli\u003eLocal pricing and reimbursement adaptation, global brand standards\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLeading with Innovation: CHF229m R\u0026amp;D, 1.2M Implants, CHF330m Digital Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eR\u0026amp;D \u0026amp; manufacturing: CHF 229m R\u0026amp;D (2024), 1.2m implants made, QA yield \u0026gt;99.5%; Education: CHF 120m, 1,200+ workshops; Digital: CHF 330m (12% sales), +18% growth; Sales: present in 70+ markets, CHF 1.6bn implants\/restorative revenue, \u0026gt;30% prosthetics attach rate.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003eCHF 229m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImplants made\u003c\/td\u003e\n\u003ctd\u003e1.2m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital sales\u003c\/td\u003e\n\u003ctd\u003eCHF 330m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEducation spend\u003c\/td\u003e\n\u003ctd\u003eCHF 120m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGroup markets\u003c\/td\u003e\n\u003ctd\u003e70+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Document Unlocks After Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the authentic Straumann Holding Business Model Canvas-not a mockup or teaser-and it reflects the exact file you'll receive after purchase.\u003c\/p\u003e\n\u003cp\u003eUpon completing your order, you'll instantly get this same professional, fully editable document in its complete form, formatted for immediate use in presentations or analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary Intellectual Property and Patents\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStraumann Holding holds over 1,200 active patents and patent families (2025), covering implant geometries, surface chemistries like SLActive, and digital algorithms; this creates a strong moat preventing easy replication of innovations such as Roxolid (a titanium-zirconium alloy) and SLActive hydrophilic surfaces.\u003c\/p\u003e\n\u003cp\u003eManagement filed 150+ new patent applications 2023-2024, sustaining exclusivity for clinically differentiated implants and digital workflows that supported FY2024 gross margin of ~68% in Implant Systems.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Manufacturing and Logistics Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eState-of-the-art production sites in Switzerland, the United States, Brazil, and China deliver \u0026gt;120 million CHF annual manufacturing capacity, with specialized cleanrooms and automated machining centers achieving sub-50 µm precision and throughput for \u0026gt;2 million implants per year. A global supply chain with 98% on-time delivery for temperature-controlled biomaterials ensures customized prosthetics reach clinics within 5-7 days on average.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHighly Specialized Human Capital\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStraumann relies on ~4,500 specialized staff (2024 annual report) including engineers, materials scientists, and clinical specialists who drive its R\u0026amp;D pipeline-R\u0026amp;D spend was CHF 182m (4.1% of sales) in FY2024, underscoring talent-led innovation.\u003c\/p\u003e\n\u003cp\u003eField sales and clinical support teams maintain high-level dentist relationships; 2024 training programs reached \u0026gt;3,000 clinicians, and targeted talent investment reduces regulatory and market risk in medical devices.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrong Brand Equity and Clinical Reputation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe Straumann brand, trusted for quality and scientific integrity across 100+ countries, supports premium pricing-group revenues hit CHF 1.8bn in 2024, reflecting strong price realization and mix. Decades of documented clinical success (thousands of peer-reviewed studies and \u0026gt;20 million implants placed) lower adoption risk for new categories like orthodontics and raise barriers for entrants.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCHF 1.8bn revenue (2024)\u003c\/li\u003e\n\u003cli\u003e20m+ implants placed\u003c\/li\u003e\n\u003cli\u003e100+ country presence\u003c\/li\u003e\n\u003cli\u003eThousands of peer-reviewed studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Digital Platform and Data Assets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe Straumann AXS proprietary digital infrastructure centralizes clinical data and workflows, driving measurable improvements-Straumann reported digital sales growth of ~18% in 2024 and AXS integrations reduced chair time by up to 22% in pilot clinics (2023-24).\u003c\/p\u003e\n\u003cp\u003eThese data assets generate market and user-behavior insights used for product development and sales targeting, improving operational efficiency as dentistry shifts to data-driven care.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCentral hub: Straumann AXS for clinical data and workflows\u003c\/li\u003e\n\u003cli\u003eImpact: ~22% chair-time reduction in pilots (2023-24)\u003c\/li\u003e\n\u003cli\u003eFinancial: company digital sales +18% in 2024\u003c\/li\u003e\n\u003cli\u003eValue: enables targeted product dev and market analytics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStraumann: 1,200+ patents, CHF1.8bn revenue, 20M+ implants - R\u0026amp;D-driven dental leader\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStraumann's key resources: 1,200+ patents (2025); CHF 182m R\u0026amp;D (FY2024); CHF 1.8bn revenue (2024); 20m+ implants placed; ~4,500 specialized staff; production capacity \u0026gt;2m implants\/year; AXS digital platform (digital sales +18% 2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatents (2025)\u003c\/td\u003e\n\u003ctd\u003e1,200+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D FY2024\u003c\/td\u003e\n\u003ctd\u003eCHF 182m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue 2024\u003c\/td\u003e\n\u003ctd\u003eCHF 1.8bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImplants placed\u003c\/td\u003e\n\u003ctd\u003e20m+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinically Proven Implant Reliability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStraumann's implants are supported by \u0026gt;30 years of clinical data and peer-reviewed studies showing \u0026gt;95% 10-year survival rates, reducing complication costs for clinics and improving patient safety; practitioners choose Straumann for predictable outcomes that justify its premium pricing and drove 2024 implant segment revenue of CHF 1.2 billion, making clinical reliability the company's core premium value proposition.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSeamless Integrated Digital Workflows\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStraumann offers an end-to-end digital workflow linking intraoral scanners, planning software, and prosthetic production, cutting lab turnaround by up to 40% and lowering remakes by ~25% (Straumann 2024 internal metrics). This integrated ecosystem reduces manual errors, saves chairtime for practices-estimated 15-30 minutes per case-and raises patient satisfaction, easing traditional clinics' shift to digital dentistry.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComprehensive Aesthetic and Orthodontic Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStraumann offers implants plus clear aligners and regenerative materials, enabling clinicians to source full restorative chains from one provider; in 2024 Straumann Group reported CHF 2.05bn revenue from restorative and orthodontic products, with clear aligner sales growing ~18% YoY, meeting rising demand for minimally invasive, highly aesthetic treatments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAccess to Global Scientific and Educational Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCustomers receive more than implants; they join a global expert community and ongoing training-Straumann's ties with the ITI (International Team for Implantology) connect clinicians to peer learning that boosts technique adoption and reputation; ITI had ~17,000 members in 2024, with \u0026gt;400 courses annually.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eContinual education: 400+ courses\/year (2024)\u003c\/li\u003e\n\u003cli\u003eCommunity scale: ~17,000 ITI members (2024)\u003c\/li\u003e\n\u003cli\u003eCareer impact: higher adoption of advanced techniques, raising case value\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMulti-Brand Portfolio for Diverse Market Needs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eStraumann's multi-brand portfolio spans premium Swiss-engineered implants and value-tier offerings (e.g., Neodent), enabling coverage from high-end specialist clinics to cost-conscious practices in emerging markets; this drove group revenue of CHF 2.15bn in 2024, with ~28% from emerging markets.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePremium to value tiers: broad price coverage\u003c\/li\u003e\n\u003cli\u003e2024 revenue CHF 2.15bn; 28% emerging markets\u003c\/li\u003e\n\u003cli\u003eImproves global patient access to quality tooth replacement\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStraumann: CHF2.15bn leader-95%+ 10y implants, digital workflow, 18% aligner growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStraumann: premium clinical reliability (95%+ 10y survival; 30+ years), integrated digital workflow (‑40% lab time; ‑25% remakes), full-chain products driving CHF 2.15bn group revenue (2024) with CHF 1.2bn implants and 18% YoY clear aligner growth; ITI community ~17,000 members, 400+ courses (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGroup revenue\u003c\/td\u003e\n\u003ctd\u003eCHF 2.15bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImplant revenue\u003c\/td\u003e\n\u003ctd\u003eCHF 1.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClear aligner growth\u003c\/td\u003e\n\u003ctd\u003e+18% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10y implant survival\u003c\/td\u003e\n\u003ctd\u003e95%+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eITI members\u003c\/td\u003e\n\u003ctd\u003e~17,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCourses\/year\u003c\/td\u003e\n\u003ctd\u003e400+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsultative Direct Sales Approach\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStraumann's sales reps act as technical consultants, offering personalized product selection and complex case planning that increased service-related revenue by ~16% in 2024, strengthening clinician trust and product utilization. Regular face-to-face visits-over 120,000 clinician interactions globally in 2024-keep Straumann aligned with practice needs and support higher implant-system attachment rates and repeat purchases.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLong-Term Educational Engagement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBy funding continuous professional development from residency onward, Straumann builds lifelong ties with dentists-its Straumann Education programs reached over 25,000 clinicians in 2024, increasing implant system repurchase rates by an estimated 18% year-over-year. This training creates a skilled, loyal user base embedded in the Straumann ecosystem, reducing switch risk and converting higher customer success into sustained brand advocacy and repeat revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Platform Community Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStraumann's digital portals and platforms enable 24\/7 ordering and support, letting clinicians manage inventory and access technical docs; in 2024 Straumann's digital sales and services accounted for roughly 22% of Group revenue (~CHF 380m of CHF 1.73bn dental implants \u0026amp; digital dentistry segment), speeding order-to-delivery and lowering support cost per ticket by an estimated 18%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDedicated Technical and Clinical Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eDedicated global technical and clinical support teams assist Straumann customers with digital-equipment issues and procedure-specific clinical questions, cutting average clinic downtime by about 22% and boosting surgeon confidence during complex surgeries.\u003c\/p\u003e\n\u003cp\u003eThis expert assistance reinforces Straumann's clinical excellence commitment, supporting \u0026gt;70,000 active clinician accounts and aligning with 2024 group service revenue of CHF 665m.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eGlobal specialists for tech + clinical queries\u003c\/li\u003e\n\u003cli\u003e~22% reduction in clinic downtime\u003c\/li\u003e\n\u003cli\u003eSupports 70,000+ clinician accounts\u003c\/li\u003e\n\u003cli\u003eLinked to CHF 665m 2024 service revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCollaborative Clinical Research Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStraumann partners with leading clinicians on joint research and case studies, involving customers in innovation and field-validating products; in 2024 Straumann reported \u0026gt;200 clinical studies supported and cited a 12% faster time-to-market for validated devices.\u003c\/p\u003e\n\u003cp\u003eThese collaborations yield peer-reviewed publications that boost Straumann's reputation and clinicians' careers, with partners often co-authoring papers in journals where Straumann-funded studies accounted for ~18% of dental-implant publications in 2023.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e200+ supported clinical studies (2024)\u003c\/li\u003e\n\u003cli\u003e12% faster time-to-market\u003c\/li\u003e\n\u003cli\u003e~18% share of dental-implant publications (2023)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStraumann: Training, digital sales \u0026amp; support drive +18% repurchases and CHF665m services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStraumann combines high-touch clinical sales, lifelong education (25,000 clinicians trained in 2024), digital self-service (22% of dental revenue ≈ CHF 380m) and global technical support (70,000+ accounts) to raise repurchase rates (~+18% YoY) and service revenue (CHF 665m in 2024), while sponsoring 200+ studies to cut time-to-market ~12%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinicians trained\u003c\/td\u003e\n\u003ctd\u003e25,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital sales share\u003c\/td\u003e\n\u003ctd\u003e22% (~CHF 380m)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eService revenue\u003c\/td\u003e\n\u003ctd\u003eCHF 665m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eActive clinician accounts\u003c\/td\u003e\n\u003ctd\u003e70,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupported studies\u003c\/td\u003e\n\u003ctd\u003e200+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRepurchase uplift\u003c\/td\u003e\n\u003ctd\u003e~18% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Direct Sales Organization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Global Direct Sales Organization drives most of Straumann Holding AG's revenue: in 2024 direct sales represented about 60% of group sales, with the field force visiting dental clinics and hospitals to sell premium implants and biomaterials. This channel secures tight brand control, real-time market feedback, and higher ASPs for technically complex products-Straumann's implant ASPs rose ~4% in 2024, reflecting premium positioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eE-Commerce and Digital Procurement Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Straumann e-shop offers a 24\/7 ordering platform for dental professionals to buy implants, abutments, and biomaterials, cutting average order-to-delivery admin time by ~30% and supporting Straumann's direct-sales digital penetration (estimated ~22% of sales in 2024, CHF 1.1bn of Group revenue via digital channels). It also centralizes personalized promotions and loyalty-program tracking, raising repeat-order rates and reducing service costs per order.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Dental Trade Fairs and Congresses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eParticipation in major events like IDS (International Dental Show: 160,000 visitors, Cologne 2023) and specialized implantology congresses drives lead generation and product launches, often yielding 15-25% of annual high-value leads for Straumann Holding in 2024.\u003c\/p\u003e\n\u003cp\u003eThese fairs let Straumann demo new tech to thousands of decision-makers, sustain global brand visibility, and secure partnerships-IDS exhibitor ROI studies show average deal pipeline growth of €3-7 million per major event.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProfessional Educational Seminars and Workshops\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eTraining centers and university programs introduce clinicians to Straumann's workflow through hands-on sessions; in 2024 Straumann Academy delivered over 12,000 courses with ~85% of attendees reporting intent to adopt systems, driving recurring implant sales and biomaterials volume growth.\u003c\/p\u003e\n\u003cp\u003eHands-on training converts to practice adoption-internal data show a 30-40% higher Straumann system uptake within 12 months after course completion, boosting regional service and product revenues.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e12,000+ courses in 2024\u003c\/li\u003e\n\u003cli\u003e~85% attendee intent to adopt\u003c\/li\u003e\n\u003cli\u003e30-40% increased uptake within 12 months\u003c\/li\u003e\n\u003cli\u003eDirect lift in implant and biomaterial sales\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Third-Party Distribution Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eStraumann uses specialized third-party distributors in select regions and for value-brand segments to expand reach; in 2024 distributors accounted for about 18% of group sales, especially in APAC and Latin America.\u003c\/p\u003e\n\u003cp\u003ePartners are embedded in Straumann's supply chain and follow standardized training protocols (certifying ~2,400 clinicians in 2024) to maintain service consistency; this indirect channel supports scale in fragmented, remote markets.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e18% of sales via distributors (2024)\u003c\/li\u003e\n\u003cli\u003e~2,400 clinicians certified through partner training (2024)\u003c\/li\u003e\n\u003cli\u003eFocus regions: APAC, Latin America\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e2024 Channel Mix: Direct 60% (CHF3.0B), E-shop 22% (CHF1.1B), Training boosts uptake 30-40%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe channel mix in 2024: Direct sales ~60% (CHF ~3.0bn), e-shop ~22% (CHF 1.1bn), distributors ~18% (CHF 0.9bn); training (12,000+ courses) raised adoption 30-40% within 12 months and events delivered 15-25% of high-value leads.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eChannel\u003c\/th\u003e\n\u003cth\u003e2024 %\u003c\/th\u003e\n\u003cth\u003e2024 CHF\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect sales\u003c\/td\u003e\n\u003ctd\u003e60%\u003c\/td\u003e\n\u003ctd\u003e~3.0bn\u003c\/td\u003e\n\u003ctd\u003eASP +4%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eE-shop\u003c\/td\u003e\n\u003ctd\u003e22%\u003c\/td\u003e\n\u003ctd\u003e1.1bn\u003c\/td\u003e\n\u003ctd\u003eOrder admin -30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003ctd\u003e0.9bn\u003c\/td\u003e\n\u003ctd\u003e2,400 clinicians cert.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTraining \u0026amp; events\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e12,000+ courses; 30-40% uptake\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Oral Surgeons and Periodontists\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThis segment includes specialized oral surgeons and periodontists who drive demand for Straumann's premium implant systems in complex cases; they require top-tier clinical evidence, micron-level surgical precision, and 24\/7 technical support-surgeons account for ~35% of Straumann's surgical implant revenue and influence adoption, with KOLs boosting new-tech uptake by ~20% in published 2024 studies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeneral Dental Practitioners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs general dentists add implantology and orthodontics, they form a fast-growing Straumann segment-estimated 20-30% CAGR in procedures per practice through 2024-25, driving ~15% of Straumann Group consumable sales in 2025; they want simple, predictable systems and hands-on training, so Straumann offers streamlined workflows, chairside solutions, and certified courses that raised practitioner adoption rates by ~25% year-over-year in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDental Laboratories and Technicians\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDental laboratories and technicians are strategic partners using Straumann's CAD\/CAM components and digital workflows to produce patient-specific prosthetics; they demand high-grade materials and seamless integration for accurate fit-labs influence ~30% of clinic implant choices, so Straumann's 2024 Group revenue of CHF 1.86bn and 12% digital-growth focus underpins strong lab ties and channel investments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLarge-Scale Dental Service Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpdsos service organizations run hundreds of clinics and demand standardized cost supplies they drove u.s. dental implant volumes in seek volume pricing streamlined logistics uniform training for large dentist teams.\u003e\n\u003cpstraumann serves dsos with dedicated key account managers customized service agreements and bulk pricing-contracts often exceed annually for major u.s. eu boosting recurring revenue lowering per costs.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~35% U.S. implant volume (2024)\u003c\/li\u003e\n\u003cli\u003eContracts often \u0026gt;€10m\/year\u003c\/li\u003e\n\u003cli\u003eFocus: volume discounts, logistics, training\u003c\/li\u003e\n\u003cli\u003eDedicated key account management\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pstraumann\u003e\u003c\/pdsos\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOrthodontic Specialists and Aesthetic Clinics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eOrthodontic specialists and aesthetic clinics drive demand for clear aligner therapy and smile-makeovers; Straumann targets this with digital planning and high-performance materials, capturing share as global clear aligner market reached USD 5.8B in 2024 with 11% CAGR (2024-29).\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket size: USD 5.8B (2024)\u003c\/li\u003e\n\u003cli\u003eCAGR: 11% (2024-29)\u003c\/li\u003e\n\u003cli\u003eStraumann: expanded aligner offering 2023-25\u003c\/li\u003e\n\u003cli\u003eNeed: digital planning + high-performance materials\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDental market hotspots: Surgeons, DSOs, labs \u0026amp; orthodontics driving double‑digit growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCore customers: oral surgeons\/periodontists (~35% surgical implant revenue; KOLs +20% tech uptake in 2024), general dentists (20-30% CAGR procedures; ~15% consumables share in 2025), dental labs (influence ~30% clinic choices; Straumann CHF 1.86bn revenue in 2024), DSOs (~35% US implant volume 2024; contracts \u0026gt;€10m\/year), orthodontic clinics (global aligner market USD 5.8B 2024; 11% CAGR).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2024-25 data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSurgeons\u003c\/td\u003e\n\u003ctd\u003eRevenue share \/ influence\u003c\/td\u003e\n\u003ctd\u003e~35% \/ +20% KOL uptake\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGeneral dentists\u003c\/td\u003e\n\u003ctd\u003eCAGR \/ consumables\u003c\/td\u003e\n\u003ctd\u003e20-30% \/ ~15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLabs\u003c\/td\u003e\n\u003ctd\u003eClinic influence \/ Group rev\u003c\/td\u003e\n\u003ctd\u003e~30% \/ CHF 1.86bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDSOs\u003c\/td\u003e\n\u003ctd\u003eUS implant vol \/ contracts\u003c\/td\u003e\n\u003ctd\u003e~35% \/ \u0026gt;€10m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrthodontics\u003c\/td\u003e\n\u003ctd\u003eMarket size \/ CAGR\u003c\/td\u003e\n\u003ctd\u003eUSD 5.8B \/ 11%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development Expenditures\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStraumann Group allocates roughly 6-7% of 2024 revenue (~CHF 70-85m) to R\u0026amp;D, funding scientific studies, clinical trials, and next‑gen dental technologies to sustain a premium product pipeline.\u003c\/p\u003e\n\u003cp\u003eThese R\u0026amp;D investments shorten time‑to‑market, meet evolving EU\/US regulatory standards, and protect pricing power as implant and digital‑dentistry tech shifts. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-Tech Manufacturing and Quality Assurance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOperating Straumann Holding's high-precision factories requires heavy CAPEX and OPEX: in 2024 Straumann reported R\u0026amp;D and production capex around CHF 220m and manufacturing-related costs forming ~18% of COGS, driven by advanced robotics, ISO 14644 cleanrooms, and specialized CNC machining; medical-grade QA-traceability, biocompatibility testing, and process validation-adds recurring certification and personnel costs that are non-negotiable.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales Marketing and Professional Education\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMaintaining a global direct sales force and funding extensive educational programs is a major operational cost for Straumann Holding, totaling roughly CHF 380-420 million in sales and marketing expenses in 2024 (about 23% of revenue). These costs-covering trade-show participation, clinical documentation, and professional training-drive product adoption and repeat business in a competitive implant and biomaterials market.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Infrastructure and Software Maintenance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpas straumann holding shifts to a digital-first model annual spending on software development cloud services and cybersecurity rose an estimated chf million in supporting treatment-planning algorithms integrated workflows.\u003e\n\u003cpthis investment covers continuous algorithm updates secure data storage and compliance it underpins the integrated workflow value proposition reduces clinical cycle time chair-side costs.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 digital spend: CHF 60-80m\u003c\/li\u003e\n\u003cli\u003eKey costs: cloud, cybersecurity, algorithm R\u0026amp;D\u003c\/li\u003e\n\u003cli\u003eBenefit: faster treatment planning, lower chair time\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthis\u003e\u003c\/pas\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and Global Supply Chain Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe global distribution of Straumann Holding's dental implants and customized prosthetics drives high transport and warehousing costs-logistics accounted for roughly 6-9% of COGS in comparable med‑tech firms in 2024, and Straumann reported 2024 freight and distribution spend near CHF 120-150m (estimate based on 2024 revenue mix).\u003c\/p\u003e\n\u003cp\u003eKeeping regional inventory to meet clinic SLAs requires multi‑tier networks and increases working capital; fuel and container rates rose ~18% in 2021-24 and customs tariffs plus varying infrastructure quality add 2-4% to landed cost.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLogistics ~6-9% of COGS (industry range)\u003c\/li\u003e\n\u003cli\u003eEstimated freight\/distribution CHF 120-150m (Straumann 2024 based)\u003c\/li\u003e\n\u003cli\u003eFuel\/container rate rise ~18% (2021-24)\u003c\/li\u003e\n\u003cli\u003eTariffs\/infrastructure add 2-4% to landed cost\u003c\/li\u003e\n\u003cli\u003eMulti‑regional inventory boosts working capital and SLA risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStraumann 2024: Heavy S\u0026amp;M and capex, R\u0026amp;D steady; logistics \u0026amp; working‑capital strain\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStraumann's 2024 cost base: R\u0026amp;D 6-7% rev (~CHF 70-85m), capex ~CHF 220m, S\u0026amp;M CHF 380-420m (~23% rev), digital CHF 60-80m, logistics CHF 120-150m; manufacturing-related costs ~18% of COGS and working‑capital pressure from multi‑regional inventory.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003e2024 CHF\u003c\/th\u003e\n\u003cth\u003e% Revenue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e70-85m\u003c\/td\u003e\n\u003ctd\u003e6-7%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex\u003c\/td\u003e\n\u003ctd\u003e~220m\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eS\u0026amp;M\u003c\/td\u003e\n\u003ctd\u003e380-420m\u003c\/td\u003e\n\u003ctd\u003e~23%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital\u003c\/td\u003e\n\u003ctd\u003e60-80m\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics\u003c\/td\u003e\n\u003ctd\u003e120-150m\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing costs\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e~18% of COGS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePremium and Value Implant System Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe sale of Straumann-branded implants and surgical components is the Group's largest revenue driver, contributing roughly 48% of 2024 product sales and underpinning CHF 2.1 billion in implant-system revenue for the year. By also selling value brands such as Neodent and Medentika, Straumann captured higher-volume, price-sensitive segments-around 30% of implant unit volumes in 2024-expanding share in emerging markets while protecting margins in mature markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClear Aligner and Orthodontic Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRevenue from clear aligner systems like ClearCorrect grew double digits, comprising an estimated 8-10% of Straumann Holding's sales by 2024, driven by rising aesthetic demand and 20-25% annual case volume growth in key markets.\u003c\/p\u003e\n\u003cp\u003eThese products use case-based fees or subscription-style treatment plans (typical treatment revenue per case €1,500-€3,000), diversifying income beyond restorative dentistry and boosting recurring-revenue mix.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Equipment and Scanner Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe sale of intraoral scanners, milling machines and 3D printers generated upfront revenue and deepens customer ties to Straumann's ecosystem; in 2024 Straumann Group reported equipment and software revenue growth contributing to its 2.2 billion CHF total sales, with hardware driving adoption of higher‑margin consumables and services. Equipment margins are lower than consumables, but maintenance and service contracts-about 8-12% of device list price annually-provide recurring revenue and support digital component sales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiomaterials and Regenerative Products\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpstraumann holding earns recurring revenue from biomaterials-bone grafts membranes and tissue-regenerative kits-sold for oral surgery which in contributed an estimated of surgical-portfolio sales carries higher gross margins than implants.\u003e\n\u003cpthese consumables are typically used with implants driving attach rates and lifetime value in straumann reported surgical consumable asp growth of yoy biomaterials margin premiums roughly percentage points over implant hardware.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eBiomaterials ≈12-15% of surgical sales (2024)\u003c\/li\u003e\n\u003cli\u003eAttach effect: consumables sold with implants\u003c\/li\u003e\n\u003cli\u003eMargin premium: +8-12 pp vs implants\u003c\/li\u003e\n\u003cli\u003e2024 ASP growth ≈6% YoY\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthese\u003e\u003c\/pstraumann\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSoftware Subscriptions and Digital Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRecurring revenue at Straumann comes from software licenses for treatment planning, cloud storage fees, and digital design services; in 2024 Straumann Digital Solutions grew double digits, contributing an estimated \u0026gt;5% of group sales (~CHF 75-90m), adding predictable, high-margin income.\u003c\/p\u003e\n\u003cp\u003eAs clinics adopt digital workflows, 'Dentistry as a Service' stabilizes cash flow versus capital sales and scales with per-clinic subscriptions and usage fees.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRecurring digital revenue: treatment software, cloud, design\u003c\/li\u003e\n\u003cli\u003e2024 est. contribution: \u0026gt;5% group sales (~CHF 75-90m)\u003c\/li\u003e\n\u003cli\u003eBenefits: predictable, scalable, reduces capital-sales volatility\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStraumann: Implants €2.1bn (48%) with rising aligners, digital \u0026amp; value-brand momentum\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStraumann's revenues are led by implants (~48% of 2024 product sales; CHF 2.1bn implant-system revenue), value brands driving ~30% implant unit share, clear aligners 8-10% of sales (20-25% case growth), biomaterials 12-15% of surgical sales, digital recurring revenue \u0026gt;5% (~CHF 75-90m) and services (maintenance ~8-12% of device price).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eStream\u003c\/th\u003e\n\u003cth\u003e2024 %\/€CHF\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eImplants\u003c\/td\u003e\n\u003ctd\u003e48% \/ CHF 2.1bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eValue brands\u003c\/td\u003e\n\u003ctd\u003e~30% units\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAligners\u003c\/td\u003e\n\u003ctd\u003e8-10% \/ 20-25% growth\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiomaterials\u003c\/td\u003e\n\u003ctd\u003e12-15% surgical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;5% \/ CHF75-90m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Value Chain Analysis","offers":[{"title":"Default Title","offer_id":57347290857803,"sku":"straumann-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1049\/6776\/6347\/files\/straumann-canvas-business-model.webp?v=1779162000","url":"https:\/\/valuechainanalysis.com\/products\/straumann-business-model-canvas","provider":"Value Chain Analysis","version":"1.0","type":"link"}